Search

Your search keyword '"Santosh Putta"' showing total 2 results
Start Over Author "Santosh Putta" Publisher biomed central
2 results on '"Santosh Putta"'

1. Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for response biomarker identification

Author

Carmela Cacciapuoti, Assunta Esposito, Andy Conroy, Spencer Liang, Santosh Putta, Alessandra Cesano, David B. Rosen, Gabriele Madonna, Ryan Alvarado, Ester Simeone, Paolo A. Ascierto, Drew Hotson, Rachael E. Hawtin, Mariaelena Capone, and Antonio M. Grimaldi

Subjects
Medicine(all), Biomarker identification, Immune signaling, Biochemistry, Genetics and Molecular Biology(all), business.industry, Melanoma, Systems biology, Ipilimumab, General Medicine, medicine.disease, Bioinformatics, Peripheral blood mononuclear cell, General Biochemistry, Genetics and Molecular Biology, Immunology, medicine, Oral Presentation, business, medicine.drug
Published
2014

2. Systems biology analysis of immune signaling in peripheral blood mononuclear cells (PBMC) of melanoma patients receiving ipilimumab; basis for clinical response biomarker identification

Author

Gabriele Madonna, Assunta Esposito, Paolo A. Ascierto, Mariaelena Capone, Rachael E. Hawtin, Drew Hotson, Alessandra Cesano, Ryan Alvarado, David B. Rosen, Andrew Conroy, Spencer Liang, Ester Simeone, Santosh Putta, and Antonio M. Grimaldi

Subjects
Pharmacology, Oncology, Biomarker identification, Cancer Research, medicine.medical_specialty, Immune signaling, medicine.drug_class, business.industry, Systems biology, Melanoma, Immunology, Ipilimumab, Monoclonal antibody, Bioinformatics, medicine.disease, Peripheral blood mononuclear cell, Internal medicine, Poster Presentation, medicine, Molecular Medicine, Immunology and Allergy, Adverse effect, business, medicine.drug
Abstract

Meeting abstracts Ipilimumab, an anti-CTLA-4 monoclonal antibody, is approved for treatment of unresectable/metastatic melanoma. Treatment benefits only a subset of patients (pts) and is associated with significant adverse effects. Biomarkers of pt response are needed. Single cell network profiling

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results